We conducted a prospective double-blind study in @ patients with moderate to severe Parkinson disease and motor fluctuations ( mean age @ @ years ; mean disease duration @ @ years ) who were randomized to a `` cheap '' or `` expensive '' subcutaneous `` novel injectable dopamine agonist '' placebo ( normal saline ) .